Fig. 5

Evaluation of prognostic efficacy and stability of the risk score. A: The nomogram constructed based on clinicopathological parameters and the risk score and predict the 1, 3 and 5-year DFS of patients. B: Calibration curves exhibit the consistency between the observed and predicted 1, 3 and 5-year DFS of patients. C: The forest map exhibits the results of univariate regression analyses of the risk score in different subgroups. D: Point plots of the results of pearson correlation coefficient analysis between gene expression and the risk score. E: The Kaplan-Meier curve of disease-free survival of patients in the high- and low-risk groups from the validation set, and log-rank test was to compare the difference in prognosis between the two groups. F: ROC curves of 1,3,5 years for the prognostic model related to vitamin D metabolic activity in the validation set. DFS: disease free survival